People with type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk of major adverse cardiovascular events, including heart attack, stroke or cardiovascular disease death, compared to people only taking the medication, according to a preliminary study presented at the American Heart Association's Scientific Sessions 2025, held Nov. 7–10, in New Orleans.
from Medical Xpress - latest medical and health news stories https://ift.tt/zAdQei2
